{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:44:54Z","timestamp":1763959494106},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:00:00Z","timestamp":1333497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00428-012-1228-9","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T11:12:57Z","timestamp":1333451577000},"page":"505-513","source":"Crossref","is-referenced-by-count":24,"title":["HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases"],"prefix":"10.1007","volume":"460","author":[{"given":"Thea Eline","family":"Hetland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arild","family":"Holth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivi Ann","family":"Fl\u00f8renes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes G.","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,4]]},"reference":[{"issue":"Suppl 1","key":"1228_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","volume":"83","author":"AP Heintz","year":"2003","unstructured":"Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Pecorelli S (2003) Carcinoma of the ovary. Int J Gynaecol Obstet 83(Suppl 1):135\u2013166","journal-title":"Int J Gynaecol Obstet"},{"key":"1228_CR2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519\u20132529","journal-title":"N Engl J Med"},{"key":"1228_CR3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"1228_CR4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943\u2013953","journal-title":"N Engl J Med"},{"key":"1228_CR5","doi-asserted-by":"crossref","unstructured":"Pujade-Lauraine E, Mahner S, Kaern J, Gebski V, Heywood M, Vasey P, Reinthaller A, Vergote I, Pignata S, Ferrero A (2009) A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG) J Clin Oncol 27:18\u00a0s (suppl; abstr LBA5509).","DOI":"10.1200\/jco.2009.27.18_suppl.lba5509"},{"key":"1228_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/era.09.165","volume":"10","author":"P Harter","year":"2010","unstructured":"Harter P, Hilpert F, Mahner S, Heitz F, Pfisterer J, du Bois A (2010) Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs. Expert Rev Anticancer Ther 10:81\u201388","journal-title":"Expert Rev Anticancer Ther"},{"key":"1228_CR7","first-page":"289","volume":"32","author":"I Cleynen","year":"2008","unstructured":"Cleynen I, Van De Ven WJ (2008) The HMGA proteins: a myriad of functions (review). Int J Oncol 32:289\u2013305","journal-title":"Int J Oncol"},{"key":"1228_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbagrm.2009.11.007","volume":"1799","author":"M Fedele","year":"2010","unstructured":"Fedele M, Fusco A (2010) HMGA and cancer. Biochim Biophys Acta 1799:48\u201354","journal-title":"Biochim Biophys Acta"},{"key":"1228_CR9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.2010.49","volume":"23","author":"A Mahajan","year":"2010","unstructured":"Mahajan A, Liu Z, Gellert L, Zou X, Yang G, Lee P, Yang X, Wei JJ (2010) HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol 23:673\u2013681","journal-title":"Mod Pathol"},{"key":"1228_CR10","doi-asserted-by":"crossref","unstructured":"Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I, Australian Ovarian Cancer Study Group, Gertig D, DeFazio A, Bowtell DD (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14(5198)","DOI":"10.1158\/1078-0432.CCR-08-0196"},{"key":"1228_CR11","doi-asserted-by":"crossref","first-page":"e18064","DOI":"10.1371\/journal.pone.0018064","volume":"6","author":"\u00c5 Helland","year":"2011","unstructured":"Helland \u00c5, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ, Group Australian Ovarian Cancer Study, Pearson RB, B\u00f8rresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD (2011) Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 6:e18064","journal-title":"PLoS One"},{"key":"1228_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevOncog.v13.i3.10","volume":"13","author":"B Davidson","year":"2007","unstructured":"Davidson B (2007) Biological characteristics of cancers involving the serosal cavities. Crit Rev Oncog 13:189\u2013227","journal-title":"Crit Rev Oncog"},{"key":"1228_CR13","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","volume":"6","author":"SM Park","year":"2007","unstructured":"Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E, Peter ME (2007) Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6:2585\u20132590","journal-title":"Cell Cycle"},{"key":"1228_CR14","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","volume":"104","author":"S Shell","year":"2007","unstructured":"Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME (2007) Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 104:11400\u201311405","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1228_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/0008-5472.CAN-10-2550","volume":"71","author":"J Wu","year":"2011","unstructured":"Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, Narita M, Muller W, Liu J, Wei JJ (2011) HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated though regulation of EMT genes. Cancer Res 71:349\u2013359","journal-title":"Cancer Res"},{"key":"1228_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","volume":"34","author":"JJ Wei","year":"2010","unstructured":"Wei JJ, Wu J, Luan C, Yeldandi A, Lee P, Keh P, Liu J (2010) HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes. Am J Surg Pathol 34:18\u201326","journal-title":"Am J Surg Pathol"},{"key":"1228_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.23491","volume":"123","author":"A Malek","year":"2008","unstructured":"Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Sch\u00e4fer R, Tchernitsa O (2008) HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 123:348\u2013356","journal-title":"Int J Cancer"},{"key":"1228_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih IeM, Kurman RJ (2009) Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16:267\u2013282","journal-title":"Adv Anat Pathol"},{"key":"1228_CR19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00000478-200111000-00008","volume":"25","author":"B Davidson","year":"2001","unstructured":"Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P (2001) The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 25:1405\u20131412","journal-title":"Am J Surg Pathol"},{"key":"1228_CR20","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1994.12.9.1748","volume":"12","author":"JT Thigpen","year":"1994","unstructured":"Thigpen JT, Blessing JA, Ball H, Hummel SJ, Barrett RJ (1994) Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. J Clin Oncol 12:1748\u20131753","journal-title":"J Clin Oncol"},{"key":"1228_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1228_CR22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.20946","volume":"103","author":"S Elloul","year":"2005","unstructured":"Elloul S, Elstrand MB, Nesland JM, Trop\u00e9 CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005) Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103:1631\u20131643","journal-title":"Cancer"},{"key":"1228_CR23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00428-006-0274-6","volume":"449","author":"S Elloul","year":"2006","unstructured":"Elloul S, Silins I, Trop\u00e9 CG, Benshushan A, Davidson B, Reich R (2006) Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 449:520\u2013528","journal-title":"Virchows Arch"},{"key":"1228_CR24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2007.10.002","volume":"39","author":"L Kleinberg","year":"2008","unstructured":"Kleinberg L, Holth A, Trope' CG, Reich R, Davidson B (2008) Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Hum Pathol 39:747\u2013757","journal-title":"Hum Pathol"},{"key":"1228_CR25","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.humpath.2008.03.009","volume":"39","author":"B Davidson","year":"2008","unstructured":"Davidson B, Shih IM, Wang TL (2008) Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Hum Pathol 39:1630\u20131636","journal-title":"Hum Pathol"},{"key":"1228_CR26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1582-4934.2010.01148.x","volume":"15","author":"O Vaksman","year":"2011","unstructured":"Vaksman O, Tuft Stavnes H, K\u00e6rn J, Trope' CG, Davidson B, Reich R (2011) miRNA profiling along tumor progression in ovarian carcinoma. J Cell Mol Med 15:1593\u20131602","journal-title":"J Cell Mol Med"},{"key":"1228_CR27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","volume":"177","author":"JT Park","year":"2010","unstructured":"Park JT, Chen X, Trop\u00e8 CG, Davidson B, IeM S, Wang TL (2010) Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am J Pathol 177:1087\u20131094","journal-title":"Am J Pathol"},{"key":"1228_CR28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.humpath.2010.10.025","volume":"42","author":"TE Hetland","year":"2011","unstructured":"Hetland TE, Hellesylt E, Fl\u00f8renes AV, Trop\u00e9 C, Davidson B, K\u00e6rn J (2011) Class III \u03b2-tubulin expression in advanced state serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance. Hum Pathol 42:1019\u20131026","journal-title":"Hum Pathol"},{"key":"1228_CR29","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M K\u00f6bel","year":"2008","unstructured":"K\u00f6bel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5:e232","journal-title":"PLoS Med"},{"key":"1228_CR30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","volume":"131","author":"F Yu","year":"2007","unstructured":"Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109\u20131123","journal-title":"Cell"},{"key":"1228_CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1006711320107","volume":"18","author":"HS Berner","year":"2000","unstructured":"Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM (2000) Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications. Clin Exp Metastasis 18:197\u2013202","journal-title":"Clin Exp Metastasis"},{"key":"1228_CR32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.stem.2008.10.008","volume":"3","author":"A Tzatsos","year":"2008","unstructured":"Tzatsos A, Bardeesy N (2008) Ink4a\/Arf regulation by let-7b and Hmga2: a genetic pathway governing stem cell aging. Cell Stem Cell 3:469\u2013470","journal-title":"Cell Stem Cell"},{"key":"1228_CR33","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial\u2013mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"1228_CR34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial\u2013mesenchymal transition. J Clin Invest 119:1420\u20131428","journal-title":"J Clin Invest"},{"key":"1228_CR35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M","volume":"192","author":"B Davidson","year":"2000","unstructured":"Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Trop\u00e8 CG, Kristensen GB, Bryne M, Ann Florenes V (2000) E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 192:460\u2013469","journal-title":"J Pathol"},{"key":"1228_CR36","doi-asserted-by":"crossref","first-page":"33437","DOI":"10.1074\/jbc.M802016200","volume":"283","author":"S Thuault","year":"2008","unstructured":"Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A (2008) HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 283:33437\u201333446","journal-title":"J Biol Chem"},{"key":"1228_CR37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2011.04.033","volume":"122","author":"L Lu","year":"2011","unstructured":"Lu L, Schwartz P, Scarampi L, Rutherford T, Canuto EM, Yu H, Katsaros D (2011) MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management. Gynecol Oncol 122:366\u2013371","journal-title":"Gynecol Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-012-1228-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1228-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T13:33:24Z","timestamp":1561556004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-012-1228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,4]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s00428-012-1228-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,4]]}}}